The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis

Purpose The prognostic role of matrix metalloproteinase 2 (MMP-2) in gastric cancer remains controversial. We systematically reviewed the evidence for assessment of MMP-2 expression in gastric cancer to elucidate this issue. Method Pubmed, Embase and Web of Science were searched to identify eligible...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and clinical oncology 2014-06, Vol.140 (6), p.1003-1009
Main Authors: Shen, Weisong, Xi, Hongqing, Wei, Bo, Chen, Lin
Format: Article
Language:English
Subjects:
Biomarkers
Biomarkers, Tumor - metabolism
Cancer Research
Case-Control Studies
Enzymes
Gastric cancer
Hematology
Humans
Internal Medicine
Matrix Metalloproteinase 2 - metabolism
Medical prognosis
Medicine
Medicine & Public Health
Oncology
Original Article - Clinical Oncology
Prognosis
Stomach Neoplasms - diagnosis
Stomach Neoplasms - enzymology
Systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The prognostic role of matrix metalloproteinase 2 (MMP-2) in gastric cancer remains controversial. We systematically reviewed the evidence for assessment of MMP-2 expression in gastric cancer to elucidate this issue. Method Pubmed, Embase and Web of Science were searched to identify eligible studies to evaluate the association of MMP-2 expression and overall survival and clinicopathological features of gastric cancer. Results MMP-2 overexpression was significantly correlated with poor OS of gastric cancer patients (HR 1.92, 95 % CI 1.48–2.48). Subgroup analysis indicated that MMP-2 overexpression had an unfavorable impact on OS in Asian countries (HR 2.23, 95 % CI 1.57–3.17) and European countries (HR 1.43, 95 % CI 1.13–1.80). Furthermore, MMP-2 overexpression was significantly associated with TNM stage (TIII/TIV vs TI/TII: OR 2.17, 95 % CI 1.64–2.87), the depth of invasion (T3/T4 vs T1/T2: OR 2.59, 95 % CI 1.63–4.12), lymph node metastasis (positive vs negative: OR 2.21, 95 % CI 1.69–2.88), and distant metastasis (positive vs negative: OR 4.44, 95 % CI 1.24–15.94). Conclusion This meta-analysis indicated that MMP-2 overexpression might be a predictive factor for poor prognosis for gastric cancer.
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-014-1630-6